SeraCare NTRK Reference Material Panel
(GenomeWeb) — SeraCare Life Sciences has announced the commercial launch of an expanded neurotrophic tropomyosin receptor kinase (NTRK) RNA fusion material panel developed in partnership with Bayer. The panel contains 15 clinically significant RNA fusions across the NTRK1, NTRK 2, and NTRK3 genes, and can be used by clinical labs to validate their detection by next-generation sequencing methods. The firm said that the RNA fusions are present within its reference cell line GM24385, and are formalin-fixed and paraffin embedded to represent typical processed tumor sections.